Lactic acidosis and other mitochondrial disorders

Metabolism: Clinical and Experimental

Volumn 46, Issue 3, 1997, Pages 306-321

  Stacpoole, Peter W ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY BALANCE; HUMAN; HUMAN CELL; LACTIC ACIDOSIS; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0031036856     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90259-6     Document Type: Review

References (222)

1. Stacpoole PW: Lactic acidosis. Endocrinol Metab Clin North Am 22:221-245, 1993
2. Stacpoole PW, Wright EC, Baumgartner TG, et al: Natural history and course of acquired lactic acidosis in adults. Am J Med 97:47-54, 1994
3. Robinson BH: Lactic acidemia, in Sly WS, Valle E (eds): The Metabolic Basis of Inherited Diseases (ed 6). New York, NY, McGraw-Hill 1989, pp 869-888
4. Stacpoole PW, Wright EC, Baumgartner TG, et al: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 327:1564-1569, 1992
5. Murray RK, Granner DK, Mayes PA. et al (eds): Harper's Biochemistry (ed 23). East Norwalk, CT, Appleton & Lange, 1993, ch 19
6. Hatefi Y: The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015-1069, 1985
7. McCord JM: Free radicals and myocardial ischemia: Overview and outlook. Free Radic Biol Med 4:9-14, 1988
8. Sies H, Moss KM: A role of mitochondrial glutathione peroxidase in modulating mitochondrial oxidations in liver. Eur J Biochem 84:377-383, 1978
9. Reed DJ: Regulation of reductive processes by glutathione. Biochem Pharmacol 35:7-13, 1986
10. Barrell BG, Bankier AT, Drouin J: A different genetic code in human mitochondria. Nature 282:189-194, 1979
11. Anderson S, Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature 290:457-465, 1981
12. Attardi G: Biogenesis of mitochondria. Annu Rev Cell Biol 4:289-333, 1988
13. Avise JC: Ten unorthodox perspectives on evolution prompted by comparative population genetic findings on mitochondrial DNA. Annu Rev Genet 25:45-69, 1991
14. Nass S: The significance of the structural and functional similarities of bacteria and mitochondria. Int Rev Cytol 25:55-129, 1969
15. Glover LA, Lindsay JG: Targeting proteins to mitochondria: A current overview. Biochem J 284:609-620, 1992
16. Kiebler M, Keil P, Schneider H, et al: The mitochondrial receptor complex: A central role of MOM22 in mediating preprotein transfer from receptors to the general insertion pore. Cell 74:483-492, 1993
17. Arey LB: The reproductive organs and sex cells, in Developmental Anatomy (ed 6). Philadelphia, PA, Saunders, 1962
18. Wallace DC: Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256:628-632, 1992
19. Shadel GS, Clayton DA: Mitochondrial transcription initiation. J Biol Chem 268:16083-16086, 1993
20. Wallace DC: Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175-1212, 1992
21. Shoffner JM, Wallace DC: Oxidative phosphorylation diseases. Disorders of two genomes. Adv Hum Genet 19:267-330, 1990
22. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 59:1609-1623, 1992
23. Tritschler H-J, Medori R: Mitochondrial DNA alterations as a source of human disorders. Neurology 43:280-288, 1993
24. Vary TC, Siegel JH, Nakatani T, et al: Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 250:E634-E640, 1986
25. Chattha G, Arieff AI, Cummings C, et al: Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 118:37-39, 1993
26. Mhiri C, Baudrimont M, Bonne G, et al: Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction. Ann Neurol 29:606-614, 1991
27. Harman D: The biologic clock: The mitochondria? J Am Geriatr Soc 20:145-147, 1970
28. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151, 1993
29. Nohl H, Breninger V, Hegner D: Influence of mitochondrial radical formation on energy-linked respiration. Eur J Biochem 90:385-390, 1978
30. Miguel J, Economos AC, Fleming J, et al: Mitochondrial role in cell aging. Exp Gerontol 15:575-591, 1980
31. Harmon HJ, Nank S, Floyd RA: Age-dependent changes in rat brain mitochondria of synaptic and non-synaptic origins. Mech Aging Dev 38:167-177, 1987
32. Wong-Riley MTT: Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101, 1989
33. Yen T-C, Chen Y-S, King K-L, et al: Liver mitochondrial respiratory functions decline with age. Biochem Biophys Res Commun 165:994-1003, 1989
34. Trounce I, Byrne E, Marzuki S: Decline in skeletal muscle mitochondrial respiratory chain function: Possible factor in aging. Lancet 1:637-639, 1989
35. Curti D, Grangare MC, Redolfi ME, et al: Age-related modifications of cytochrome C oxidase activity in discrete brain regions. Mech Aging Dev 55:171-180, 1990
36. Paradies G, Ruggiero FM: Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria. Biochim Biophys Acta 1016:207-212, 1990
37. Corbisier P, Remacle J: Involvement of mitochondria in cell degeneration. Eur J Cell Biol 51:173-182, 1990
38. Hevner RF, Wong-Riley MTT: Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J Neurosci 13:1805-1819, 1993
39. Cortopassi GA, Shihata D, Soong N-W, et al: A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 89:7370-7374, 1992
40. Blass JP, Gibson GE: Studies of the pathophysiology of pyruvate dehydrogenase deficiency. Adv Neurol 21:181-194, 1978
41. Curti D, Benzi G: Role of synaptosomal enzymatic alterations and drug treatment in brain aging. Clin Neuropharmacol 13:559-572, 1990
42. Bogonez E. Gomez-Puertas P, Satrustegui J: Pyruvate dehydrogenase dephosphorylation in rat brain synaptosomes and mitochondria: Evidence for a calcium-mediated effect in response to depolarization, and variations due to aging. Neurosci Lett 142:123-127, 1992
43. Cooper JM, Mann VM, Schapira AHV: Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: Effect of ageing. J Neurol Sci 113:91-98, 1992
44. Torii K, Sugiyama S, Takagi K, et al: Age-related decrease in respiratory muscle mitochondrial function in rats. Am J Respir Cell Mol Biol 6:88-92, 1992
45. Bowling AC, Mutisya EM, Walker LC, et al: Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 60:1964-1967,1993
46. Sylvia AL, Rosenthal M: Effects of age on brain oxidative metabolism in vivo. Brain Res 165:235-248, 1979
47. Muller-Hocker J: Cytochrome-C-oxidase deficient cardiomyocytes in the human heart - An age-related phenomenon. Am J Pathol 134:1167-1173, 1989
48. Muller-Hocker J: Cytochrome C oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: An age-related alteration. J Neurol Sci 100:14-21, 1990
49. Grinna LS: Changes in cell membranes during aging. Gerontology 23:452-464, 1977
50. Harman D: Free radical theory of aging: Role of free radicals in the origin and evolution of life, aging, and disease processes, in Free Radicals, Aging, and Degenerative Diseases. New York, NY, Liss, 1986, pp 3-49
51. Linnane AW, Ozawa T, Marzuki S, et al: Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet 1:642-645, 1989
52. Cortopassi GA, Arnheim N: Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 18:6927-6933, 1990
53. Hattori K, Tanaka M, Sugiyama S, et al: Age-dependent increase in deleted mitochondrial DNA in the human heart: Possible contributory factor to presbycardia. Am Heart J 121:1735-1742, 1991
54. Hayakawa M, Toril K, Sugiyama S, et al: Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 179:1023-1029, 1991
55. Corral-Debrinski M, Horton T, Lott MJ, et al: Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet 2:324-329, 1992
56. Nohl H: Oxygen radical release in mitochondria: Influence of age, in Free Radicals, Aging, and Degenerative Diseases. New York, NY, Liss, 1986, pp 77-97
57. Vlessis AA, Mela-Riker L: Perinatal development of heart, kidney, and liver mitochondrial antioxidant defense. Pediatr Res 26:220-226, 1989
58. Bandy B, Davison AJ: Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:423-539, 1990
59. 2max, and response to endurance training. Med Sci Sports Exerc 23:177-185, 1991
60. Zhou Y-P, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
61. Randle PJ, Kerbey AL, Espinal J: Mechanisms decreasing glucose oxidation in diabetes and starvation: Role of lipid fuels and hormones. Diabetes Metab Rev 4:623-638, 1988
62. MacDonald MJ: Elusive proximal signals of β-cells for insulin secretion. Diabetes 39:1461-1466, 1990
63. Stacpoole PW, Moore GW, Kornhauser DM: Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 298:526-530, 1978
64. Thornburn AW, Gumbiner B, Bulacan F, et al: Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85:522-529, 1990
65. Henry RR, Gumbiner B, Glynn T, et al: Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. Diabetes 39:149-156, 1990
66. Reardon W, Ross RJM, Sweeney MG, et al: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379, 1992
67. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371, 1992
68. Leu- (UUR) gene. Lancet 341:1291-1292, 1993
69. Leu(UUR) gene. FEBS Lett 321:194-196, 1993
70. Oka Y, Katagiri H, Yazaki Y, et al: Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 342:527-528, 1993
71. Leu(UUR) mutation. Neurology 43:1015-1020, 1993
72. Alcolado JC, Majid A, Brockington M, et al: Mitochondrial gene defects in patients with NIDDM. Diabetologia 37:372-376, 1994
73. Kadowaki T, Kadowaki H, Mori Y, et al: A subtype of diabetes mellitus associated with a mutation in the mitochondrial gene. N Engl J Med 330:962-968, 1994
74. Kanamore A, Tanaka K, Umezawa S-I, et al: Insulin resistance in mitochondrial gene mutation. Diabetes Care 17:778-779, 1994
75. Leu(UUR) gene. Diabetes 43:746-751, 1994
76. Leu(UUR) gene. Diabetes Care 18:1023-1028, 1995
77. Leu(UUR) mutation. Diabetes Care 18:1507-1509, 1995
78. Leu(UUR) gene. FEBS Lett 321:194-196, 1993
79. Pettitt DJ, Aleck KA, Baird HR, et al: Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 37:622-628, 1988
80. Alcolado JC, Alcolado R: Importance of maternal history of non-insulin dependent diabetic patients. Br Med J 302:1178-1180, 1991
81. Cox NJ: Maternal component in NIDDM transmission. How large an effect? Diabetes 43:166-168, 1994
82. Thomas F, Balkau B, Vauzelle-Kervroedan F, et al: Maternal effect and familial aggregation in NIDDM. Diabetes 43:63-67, 1994
83. Freinkel N, Metzger BE, Phelps RL, et al: Gestational diabetes mellitus: A syndrome with phenotypic and genotypic heterogeneity. Horm Metab Res 18:427-430, 1986
84. Dorner G, Plagemann A, Reinagel H: Familial diabetes aggregation in type I diabetes: Gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring. Exp Clin Endocrinol 89:84-90, 1987
85. Gerbitz K-D: Does the mitochondrial DNA play a role in the pathogenesis of diabetes? Diabetologia 35:1181-1186, 1992
86. Erecinska M, Silver IA: ATP and brain function. J Cereb Blood Flow Metab 9:2-19, 1989
87. Volpe J: Hypoxic-ischemic encephalopathy: Biochemical and physiological aspects, in WB Saunders Staff (eds): Neurology of the Newborn (ed 2). Philadelphia, PA, Saunders, 1987, pp 160-279
88. Cerutti PA: Prooxidant states and tumor promotion. Science 227:375-380, 1985
89. Bolli R: Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol 12:239-249, 1988
90. Krause GS, White BC, Aust SD, et al: Brain cell death following ischemia and reperfusion: A proposed biochemical sequence. Crit Care Med 16:714-726, 1988
91. Marklund SL: Role of toxic effects of oxygen in reperfusion damage. J Mol Cell Cardiol 20:23-30, 1988
92. Bruckner BA, Otal MP, Raizada MK, et al: Transcriptional and post-transcriptional regulation of brain glucose transporters by glucose and oxygen starvation, (submitted)
93. 2 in muscle cells in culture. Am J Physiol 262:C682-C690, 1992
94. Cross CE, Halliwell B, Borish ET, et al: Oxygen radicals and human disease. Ann Intern Med 107:526-545, 1987
95. Halliwell B, Gutteridge JMC: Oxygen radicals and the nervous system. Trends Neurosci 8:22-26, 1985
96. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186:1-85, 1990
97. Ferrari R, Ceconi C, Curello S, et al: Oxygen-mediated myocardial damage during ischaemia and reperfusion: Role of the cellular defenses against oxygen toxicity. J Mol Cell Cardiol 17:937-945, 1985
98. Plum D: What causes infarction in ischemic brain?: The Robert Wartenberg Lecture. Neurology 33:222-233, 1983
99. Hillered L, Ernster L, Siesjo BK: Influence of in vitro lactic acidosis and hypercapnia on respiratory activity of isolated rat brain mitochondria. J Cereb Blood Flow Metab 4:430-437, 1984.
100. Siesjo BK, Bendek G, Koide T, et al: Influence of acidosis on lipid peroxidation in brain tissues in vitro. J Cereb Blood Flow Metab 5:253-258, 1985
101. Nedergaard M, Diemer NH: Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration. Acta Neuropathol 73:131-137, 1987
102. Siesjo BK: Mechanisms of ischemic brain damage. Crit Care Med 16:954-963, 1988
103. 2. J Cereb Blood Flow Metab 9:65-70, 1989
104. Walz W, Harold DE: Brain lactic acidosis and synaptic function. Can J Physiol Pharmacol 68:164-169, 1989
105. Bralet J, Bouvier C, Schreiber L, et al: Effect of acidosis on lipid peroxidation in brain slices. Brain Res 539:175-177, 1991
106. Gibson GE, Pulsinelli W, Blass JP, et al: Brain dysfunction in mild to moderate hypoxia. Am J Med 70:1247-1264, 1981
107. Bak MI, Ingwall JS: Acidosis during ischemia promotes adenosine triphosphate resynthesis in post-ischemic rat heart. J Clin Invest 93:40-49, 1994
108. Giffard RG, Monyer H, Christine CW, et al: Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygenglucose deprivation neuronal injury in cortical culture. Brain Res 506:339-342, 1990
109. Traynelis SF, Cull-Candy SG: Proton inhibition of n-methyl-D-aspartate receptors in cerebellar neurons. Nature 345:347-350, 1990
110. Kaku DA, Goldberg MP, Choi DW: Antagonism of non-NMDA receptors augments the rieuroprotective effect of NMDA receptor blockage in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res 554:344-347, 1991
111. Tombaugh GC, Sapolsky RM: Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem 61:793-803, 1993
112. Rovetto MJ, Lamberton WF, Neely JR: Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res 37:742-751, 1975
113. Schmidt-Kastner R, Hossman K-A, Grosse-Ophoff BG: Relationship between metabolic recovery and the EEG prolonged ischemia of cat brain. Stroke 17:1164-1169, 1986
114. Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 258:C967-C981, 1990
115. Albin RL, Greenamyre JT: Alternative excitotoxic hypothesis. Neurology 42:733-738, 1992
116. Novelli A, Reilly IA, Lysko PG, et al: Glutamate becomes neurotoxic via the n-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205-212, 1988
117. Henneberry RC, Novelli A, Cox JA, et al: Neurotoxicity at the n-methyl-D-aspartate receptor in energy-compromised neurons. Ann NY Acad Sci 568:225-233,1989
118. Barinaga M: New accomplices in cell death. Science 262:1211-1212, 1993
119. Lipton SA, Choi Y-B, Pan Z-H, et al: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632, 1993
120. 2+ concentration and pHi during metabolic inhibition. Am J Physiol 262:C628-C634, 1992
121. Braunwald E, Kloner RA: Myocardial reperfusion: A double-edged sword? J Clin Invest 76:1713-1719, 1985
122. Dubinsky JM, Rothman SM: Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci 11:2545-2551, 1991
123. Sirivech S, Frieden E, Osaki S: The release of iron from horse spleen ferritin by reduced flavins. Biochem J 143:311-315, 1974
124. Theil EC: Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 56:289-315, 1987
125. Zweier JL, Rayburn BK, Flaherty JT, et al: Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium. J Clin Invest 80:1728-1734, 1987
126. Cohen MV: Free radicals in ischemic and reperfusion myocardial injury: Is this the time for clinical trials? Ann Intern Med 11:918-931, 1989
127. Zweier JL, Kuppusamy P, Williams R, et al: Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 264:18890-18895, 1989
128. Ambrosio G, Flaherty JT, Duilio C, et al: Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87:2056-2066, 1991
129. Abate C, Patel L, Rauscher FJ, et al: Redox regulation of fos and jun DNA-binding activity. Science 249:1157-1161, 1990
130. Crane D, Haussinger D, Graf P, et ai: Decreased flux through pyruvate dehydfogenase by thiol oxidation during t-butyl hydroperoxide metabolism in perfused rat liver. Hoppe-Seyler's Z Physiol Chem 364:977-987, 1983
131. Meister A: Glutathione metabolism and its selective modification. J Biol Chem 263:17205-17208, 1988
132. Sohal RS, Orr WC: Relationship between antioxidants, prooxidants, and the aging process. Ann NY Acad Sci 663:74-84,1992
133. Paetzke-Brunner I; Wieland OH: Activation of the pyruvate dehydrogenase complex in isolated fat cell mitochondria by hydrogen peroxide and t-butyl hydrpperoxide. FEBS Lett 122:29-32, 1980
134. Petit FH, Humphreys J, Reed LJ: Regulation of pyruvate dehydrogenase kinase activity by protein thiol-disulfide exchange. Proc Natl Acad Sci USA 79:3945-3948, 1982
135. Cremer J, Teal H: The activity of pyruvate dehydrogenase in rat brain during post-natal development. FEBS Lett 39:17-20, 1974
136. Blass J, Gibson G: Studies of the pathophysiology of pyruvate dehydrogenase deficiency. Adv Neurol 21:181-194, 1978
137. Browning M, Baudry M, Bennett WF, et al: Phosphorylation-mediated changes in pyruvate dehydrogenase activity influence pyruvate-supported calcium accumulation by brain mitochondria. J Neurochem 36:1932-1940, 1981
138. Morgan DG, Routtenberg A: Brain pyruvate dehydrogenase: Phosphorylation and enzyme activity altered by a training experience. Science 214:470-471, 1981
139. Browning M, Dunwiddie T, Bennett W, et al: Synaptic phosphoproteins: Specific changes after repetitive stimulation of the hippocampal slice. Science 203:60-62, 1979
140. Randle PJ, Tubbs PK: Carbohydrate and fatty acid metabolism, in Berne RM (ed): Handbook of Physiology, vol 1 (ed 2). Baltimore, MD, Waverly, 1979, pp 805-844
141. Paolisso G, Gambardella A, Galzerano D, et al: Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 43:174-179, 1994
142. Corral-Debrinski M, Stepien G, Shoffner JM, et al: Hypoxemia is associated with mitochondrial DNA damage and gene induction. JAMA 266:1812-1816, 1991
143. Ozawa T, Tanaka M, Sugiyama S, et al: Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy. Biochem Biophys Res Commun 170:830-836, 1990
144. Leu(UUR). Lancet 338:143-147, 1991
145. Obayashi T, Hattori K, Sugiyama S, et al: Point mutations in mitochondrial DNA. in patients with hypertrophic cardiomyopathy. Am Heart J 124:1263-1269, 1992
146. Anan R, Nakagawa M, Miyata M, et al: Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 91:955-961, 1995
147. Harding AE: Neurological disease and mitochondrial genes. Trends Neurosci 14:132-138, 1991
148. Beal MF, Hyman BT, Korshetz W: Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16:125-131, 1993
149. Kumar A, Newberg A, Alavi A, et al: Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: Preliminary position emission tomography study. Proc Natl Acad Sci USA 90:7019-7023, 1993
150. Perry EK, Perry RH, Tomlinson BE, et al: Coenzyme A-acetylating enzymes in Alzheimer's disease: Possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett 18:105-110, 1980
151. Sorbi S, Bird ED, Blass JP: Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13:72-78, 1983
152. Sheu K-FR, Kim H-T, Blass JP, et al: An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol 17:444-449, 1985
153. Butterworth RJ, Besnard A-M: Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease. Metab Brain Dis 5:179-184, 1990
154. Taylor R: Mitochondrial DNA may hold a key to human degenerative diseases. J NIH Res 4:62-66, 1992
155. Fibiger HC: Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trends Neurosci 14:220-223, 1991
156. Parker WD, Boyson SJ, Parks JK: Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26:719-723, 1989
157. Ikebe S, Tanaka M, Ohno K, et al: Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 170:1044-1048, 1990
158. Mizumo Y, Ohta S, Tanaka M, et al: Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163:1450-1455, 1989
159. Schapira AHV, Cooper JM, Dexter D, et al: Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827, 1990
160. Shoffner JM, Watts RL, Juncos JL, et al: Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30:332-339, 1991
161. Yates CM, Butterworth J, Tennant MC, et al: Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 55:1624-1630, 1990
162. Beal MF: Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119-130, 1992
163. Koroshetz WJ, Jenkins BG, Beal MF, et al: Localized protonNMR spectroscopy in patients with Huntington's disease (HD) demonstrate abnormal lactate levels in occipital cortex: Evidence for compromised metabolism in HD. Neurology 42:319, 1992 (suppl 3, abstr)
164. Parker WD Jr, Boyson SJ, Luder AS, et al: Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40:1231-1234, 1990
165. Alnaes E, Rahamimoff R: On the role of mitochondria in transmitter release from motor nerve terminals. J Physiol 248:285-306, 1975
166. DeFronzo RA: The triumvirate: β-Cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687, 1988
167. Lysiak W, Toth PP, Suelter CH, et al: Quantitation of the efflux of acylcarnitines from rat heart, brain and liver mitochondria. J Biol Chem 261:13698-13703, 1986
168. Lysiak W, Lilly K, DiLisa F, et al: Quantitation of the effect of L-carnitine on the levels of acid-soluble short chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263:1151-1156, 1988
169. Uziel G, Garavaglia B, DiDonato S: Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11:720-724, 1988
170. Broderick TL, Quinney HA, Lopaschuk GD: Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 267:3758-3763, 1992
171. Zweier JL, Jacobus WE: Substrate-induced alterations of high energy phosphate metabolism and contractile function in the perfused heart. J Biol Chem 262:8015-8021, 1987
172. Bunger R, Mallet RT, Hartman DA: Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic working heart. Near-complete prevention of reperfusion contractile failure. Eur J Biochem 180:221-233, 1989
173. Mentzer RM Jr, Van Wylen DGL, Sodhi J, et al: Effect of pyruvate on regional ventricular function in normal and stunned myocardium. Ann Surg 209:629-634, 1989
174. Cavallini L, Valente M, Rigobello MP: The protective action of pyruvate on recovery of ischemic rat heart: Comparison with other oxidizable substrates. J Mol Cell Cardiol 22:143-154, 1990
175. Deboer LWV, Bekx PA, Han L, et al: Pyruvate enhances recovery of rat hearts after ischemia and reperfusion by preventing free radical generation. Am J Physiol 265:H1571-H1576, 1993
176. Penukurinen KJ, Takala TES, Nuutinen EM, et al: Tricarboxylic acid cycle metabolites during ischemia in isolated perfused rat heart. Am J Physiol 244:H281-H288, 1983
177. Peuhkhrinen KJ, Hassinen IE: Pyruvate carboxylation as an anaplerotic mechanism in the isolated perfused rat heart. Biochem J 202:67-76, 1982
178. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 38:1124-1144, 1989
179. Kuroda Y, Ito M, Toshima K, et al: Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis 9:244-252, 1986
180. Lopashuk GD, Saddik M: The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem 116:111-116, 1992
181. Lopaschuk GD, Wambolt RB, Barr RL: An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfu-sion of ischemic hearts. J Pharmacol Exp Ther 264:135-144, 1993
182. Okabe I, Kodama H, Shimoizumi H, et al: Treatment of lactic acidosis: Effects of dichloroacetate on lactate and pyruvate levels in the cerebrospinal fluid. Eur J Pediatr 145:159, 1986
183. Stacpoole PW, Barnes CL, Hurbanis MD, et al: Dichloroacetate as a treatment for congenital lactic acidosis. (submitted)
184. Bersin RM, Wolfe C, Kwasman M, et al: Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate. J Am Coll Cardiol 23:1617-1624, 1994
185. Wargovich TJ, Macdonald RG, Hill JA, et al: Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61:65-70, 1988
186. Chang L-H, Shimiza H, Abiko H, et al: Effect of dichloroacetate on recovery of brain lactate, phosphorous energy metabolites, and glutamate during reperfusion after complete cerebral ischemia in rats. J Cereb Blood Flow Metab 12:1030-1038, 1992
187. Barsan WG, Hedges JR, Syverud SA, et al: Effects of dichloroacetate in spinal stroke in the rabbit. Life Sci 41:1065-1069, 1987
188. LeMay DR, Zelenock GB, D'Alecy LG: Neurological protection by dichloroacetate depending on the severity of injury in the paraplegic rat. J Neurosurg 73:118-122, 1990
189. Roberson CS, Goodman JC, Grossman RG, et al: Reduction in spinal cord lactic acidosis and functional improvement with dichloroacetate. J Neurotrauma 7:1-12, 1990
190. Schaffer WT, Olson MS: The regulation of pyruvate oxidation during membrane depolarization of rat brain synaptosomes. Biochem J 192:741-751, 1980
191. Browning M, Bennett WF, Kelly P, et al: Evidence that the 40,000 Mr. phosphoprotein influenced by high frequency synaptic stimulation is the alpha subunit of pyruvate dehydrogenase. Brain Res 218:255-266, 1981
192. Baudry M, Kessler M, Smith EK, et al: The regulation of pyruvate dehydrogenase activity in rat hippocampal slices: Effect of dichloroacetate. Neurosci Lett 31:41-46, 1982
193. Kilpatrick-Smith L, Erecinska M: Cellular effects of in vivo. I. Effect of endotoxin on mitochondrial substrate metabolism and intracellular calcium. Circ Shock 11:85-99, 1983
194. Evans OB: Effect of dichloroacetate on brain tissue pyruvate dehydrogenase. J Neurochem 41:1052-1056, 1983
195. Kuroda Y, Toshima K, Watanabe T, et al: Effects of dichloroacetate on pyruvate metabolism in rat brain in vivo. Pediatr Res 18:936-938, 1984
196. Abemayor E, Kovachich GB, Haugaard N: Effects of dichloroacetate on brain pyruvate dehydrogenase. J Neurochem 42:38-42, 1984
197. Katayama Y, Welsh FA: Effect of dichloroacetate on regional energy metabolites and pyruvate dehydrogenase activity during ischemia and reperfusion in gerbil brain. J Neurochem 52:1817-1822, 1989
198. Miller AI, Hatch JP, Prihoda TJ: Dichloroacetate increases glucose use and decreases lactate in developing rat brain. Metab Brain Dis 5:195-203, 1990
199. Biros MH, Dimlich RVW: Brain lactate during partial global ischemia and reperfusion: Effect of pre-treatment with dichloroacetate in a rat model. Am J Emerg Med 5:271-277, 1987
200. Dimlich RVW, Biros MH, Widman DW, et al: Comparison of sodium bicarbonate with dichloroacetate treatment of hyperlactatemia and lactic acidosis in the ischemic rat. Resuscitation 16:13-30, 1988
201. Tomsig JL, Gruenstein E, Dimlich RVW: Inhibition of lactate-induced swelling by dichloroacetate in human astrocytoma cells. Brain Res 568:92-100, 1991
202. Dimlich RVW, Nielsen MM: Facilitating postischemic reduction of cerebral lactate in rats. Stroke 23:1145-1153, 1992
203. Constantopoulos G, Barranger JA: Nonenzymatic decarboxylation of pyruvate. Anal Biochem 139:353-358, 1984
204. Rigobello MP, Bindoli A: Effect of pyruvate on rat heart thiol status during ischemia and hypoxia followed by reperfusion. Mol Cell Biochem 122:93-100, 1993
205. Johnston CS, Meyer CG, Srilakshmi JC: Vitamin C status elevates red blood cell glutathione in healthy adults. Am J Clin Nutr 58:103-105, 1993
206. Paolisso G, D'Amore A, Balbi V, et al: Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 266:E261-E268, 1994
207. Paolisso G, DiMaro G, Pizza G, et al: Plasma GSH/G556 affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 263:E435-E440, 1992
208. Byers T: Vitamin E supplements and coronary heart disease. Nutr Rev 51:333-336, 1993
209. Gershoff SN: Vitamin C (ascorbic acid): New roles, new requirements? Nutr Rev 51:313-326, 1993
210. Kardinaal AFM, Kok FJ, Ringstad J, et al: Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC Study. Lancet 342:1379-1384, 1993
211. Kayden HJ, Traber MG: Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343-358, 1993
212. Paolisso G, D'Amore A, Gingliano D, et al: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and noninsulin-dependent diabetic patients. Am J Clin Nutr 57:650-656, 1993
213. Collier A, Wilson R, Bradley H, et al: Free radical activity in type II diabetes. Diabetic Med 7:27-30, 1990
214. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163, 1985
215. Pomposelli JJ, Flores EA, Blackburn GL, et al: Diets enriched with n-3 fatty acids ameliorate lactic acidosis by improving endotoxin-induced tissue hypoperfusion in guinea pigs. Ann Surg 213:166-176, 1991
216. Pomposelli JJ, Flores EA, Hirschberg Y, et al: Short-term TPN containing n-3 fatty acids ameliorate lactic acidosis induced by endotoxin in guinea pigs. Am J Clin Nutr 52:548-552, 1990
217. Burr MI, Gilbert JF, Holliday RM, et al: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 2:757-761, 1989
218. Dolecek TA, Grandits G: Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 66:205-216, 1991
219. Doleck TA: Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med 200:177-182, 1992
220. Malasanos TH, Stacpoole PW: Biological effects of w-3 fatty acids in diabetes mellitus. Diabetes Care 14:1160-1179, 1991
221. McLennan PL: Relative effects of dietary saturated, monounsaturated. and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr 57:207-212, 1993
222. Billman GE, Hallaq H, Leaf A: Prevention of ischemia-induced ventricular fibrillation by w-3 fatty acids. Proc Natl Acad Sci USA 91:4427-4430, 1994